The interaction of G3BP1 and GSK-3β inhibits the degradation of β-catenin in the cytoplasm and promotes the proliferation of breast cancer (122) and esophageal cancer by enhancing the stability of β-catenin (123). Here, G3BP1 is linked to breast cancer.